Spangenberg HC - Search Results

1

Influence of the transjugular intrahepatic portosystemic stent on firstline treatment of hepatocellular carcinoma.

Knüppel E, Bettinger D, Euringer W, Thimme R, Roessle M, Spangenberg HC, Schultheiβ M. Knüppel E, et al. Among authors: spangenberg hc. Hepatology. 2013 Dec;58(6):2211-2. doi: 10.1002/hep.26406. Epub 2013 Oct 21. Hepatology. 2013. PMID: 23519917 No abstract available.

2

Advances in prevention and diagnosis of hepatocellular carcinoma.

Spangenberg HC, Thimme R, Blum HE. Spangenberg HC, et al. Expert Rev Gastroenterol Hepatol. 2008 Jun;2(3):425-33. doi: 10.1586/17474124.2.3.425. Expert Rev Gastroenterol Hepatol. 2008. PMID: 19072390 Review.

3

Targeted therapy for hepatocellular carcinoma.

Spangenberg HC, Thimme R, Blum HE. Spangenberg HC, et al. Nat Rev Gastroenterol Hepatol. 2009 Jul;6(7):423-32. doi: 10.1038/nrgastro.2009.86. Epub 2009 Jun 2. Nat Rev Gastroenterol Hepatol. 2009. PMID: 19488072 Review.

4

Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma.

Bettinger D, Knüppel E, Euringer W, Spangenberg HC, Rössle M, Thimme R, Schultheiß M. Bettinger D, et al. Among authors: spangenberg hc. Aliment Pharmacol Ther. 2015 Jan;41(1):126-36. doi: 10.1111/apt.12994. Epub 2014 Oct 20. Aliment Pharmacol Ther. 2015. PMID: 25329493

5

Editorial: TIPSS in patients with cirrhosis and hepatocellular carcinoma - authors' reply.

Bettinger D, Knüppel E, Euringer W, Spangenberg HC, Rössle M, Thimme R, Schultheiß M. Bettinger D, et al. Among authors: spangenberg hc. Aliment Pharmacol Ther. 2015 Jan;41(2):231. doi: 10.1111/apt.13038. Aliment Pharmacol Ther. 2015. PMID: 25511769 No abstract available.

6

Tracking cccDNA in chronic HBV infection.

Spangenberg HC, Thimme R, Blum HE. Spangenberg HC, et al. Hepatology. 2004 Jun;39(6):1736-8. doi: 10.1002/hep.20272. Hepatology. 2004. PMID: 15185317 No abstract available.

7

Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection.

Spangenberg HC, Viazov S, Kersting N, Neumann-Haefelin C, McKinney D, Roggendorf M, von Weizsäcker F, Blum HE, Thimme R. Spangenberg HC, et al. Hepatology. 2005 Oct;42(4):828-37. doi: 10.1002/hep.20856. Hepatology. 2005. PMID: 16175596

8

Virological and immunological determinants of intrahepatic virus-specific CD8+ T-cell failure in chronic hepatitis C virus infection.

Neumann-Haefelin C, Timm J, Spangenberg HC, Wischniowski N, Nazarova N, Kersting N, Roggendorf M, Allen TM, Blum HE, Thimme R. Neumann-Haefelin C, et al. Among authors: spangenberg hc. Hepatology. 2008 Jun;47(6):1824-36. doi: 10.1002/hep.22242. Hepatology. 2008. PMID: 18454507

9

Comprehensive analysis of the alpha-fetoprotein-specific CD8+ T cell responses in patients with hepatocellular carcinoma.

Thimme R, Neagu M, Boettler T, Neumann-Haefelin C, Kersting N, Geissler M, Makowiec F, Obermaier R, Hopt UT, Blum HE, Spangenberg HC. Thimme R, et al. Among authors: spangenberg hc. Hepatology. 2008 Dec;48(6):1821-33. doi: 10.1002/hep.22535. Hepatology. 2008. PMID: 19003875

10

Evolving therapies in the treatment of hepatocellular carcinoma.

Spangenberg HC, Thimme R, Blum HE. Spangenberg HC, et al. Biologics. 2008 Sep;2(3):453-62. doi: 10.2147/btt.s3254. Biologics. 2008. PMID: 19707376 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters